Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel

• Published in: Cancer chemotherapy and pharmacology 2006-12, Vol.58 (6), p.785
• Main Authors: Takara, Kohji, Obata, Yukihisa, Yoshikawa, Eri, Kitada, Noriaki, Sakaeda, Toshiyuki, Ohnishi, Noriaki, Yokoyama, Teruyoshi
• Format: Article
• Language: English
• Subjects: Antineoplastic Agents - pharmacology; ATP Binding Cassette Transporter, Sub-Family G, Member 2; ATP-Binding Cassette Transporters - genetics; ATP-Binding Cassette, Sub-Family B, Member 1 - genetics; bcl-2-Associated X Protein - genetics; Cell Proliferation - drug effects; Cisplatin - pharmacology; Cyclosporine - pharmacology; Drug Resistance, Multiple - genetics; Drug Resistance, Neoplasm - genetics; gamma-Glutamyltransferase - genetics; Gene Expression Regulation, Neoplastic - drug effects; Gene Expression Regulation, Neoplastic - genetics; Glutamate-Cysteine Ligase - genetics; HeLa Cells; Humans; Inhibitory Concentration 50; Multidrug Resistance-Associated Proteins - genetics; Neoplasm Proteins - genetics; Paclitaxel - pharmacology; Proto-Oncogene Proteins c-bcl-2 - genetics; Receptors, Steroid - genetics; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - genetics; RNA, Messenger - metabolism; Tubulin - genetics
• ISSN: 0344-5704; 1432-0843
• DOI: 10.1007/s00280-006-0226-5

To achieve a reversal of multidrug resistance (MDR) in cancer chemotherapy, it is crucial to clarify the characteristics of MDR cells generated by various types of chemotherapeutic agents and to find novel targets. Cisplatin- and paclitaxel-resistant HeLa sublines (HeLa/CDDP and HeLa/TXL, respectively) were established by continuous exposure and their cellular changes were examined based on growth inhibition assays, the transport activity of P-glycoprotein/MDR1, and a RT-PCR analysis of MDR-related factors. HeLa/CDDP cells showed cross-resistance to platinum derivatives, whereas HeLa/TXL cells were resistant to a variety of MDR1 substrates. Transport activity of MDR1 was reduced in HeLa/CDDP cells and the expression of MDR1 was significantly accelerated in HeLa/TXL cells, compared with HeLa cells. In addition, the expression levels of MDR-related transporters (MRP1-5 or BCRP), betatubulin which is a target for taxanes, and apoptosis-regulated factors were comparable among the three cell lines. On the other hand, the mRNA levels of gamma-glutamyl transferase, but not gamma-glutamyl cysteine synthetase, were higher in HeLa/CDDP cells than in HeLa and HeLa/TXL cells. HeLa/CDDP cells showed decreased activity and expression of MDR1 and overexpression of gamma-GT but not gamma-GCS whereas the activity of MDR1 in HeLa/TXL cells was significantly enhanced. Thus, the molecular changes to HeLa cells caused by continuous exposure to cisplatin or paclitaxel were in part clarified, and therefore an understanding of the cellular changes induced by chemotherapeutic agents will be necessary to establish a strategy for reversing MDR.